Brain injury during venovenous extracorporeal membrane oxygenation

PurposeThe frequency of neurological events and their impact on patients receiving venovenous extracorporeal membrane oxygenation (VV-ECMO) are unknown. We therefore study the epidemiology, risk factors, and impact of cerebral complications occurring in VV-ECMO patients.MethodsObservational study conducted in a tertiary referral center (2006–2012) on patients developing a neurological complication (ischemic stroke or intracranial bleeding) while on VV-ECMO versus those who did not, and a systematic review on this topic.ResultsAmong 135 consecutive patients who had received VV-ECMO, 18 (15 assessable) developed cerebral complications on ECMO: cerebral bleeding in 10 (7.5 %), ischemic stroke in 3 (2 %), or diffuse microbleeds in 2 (2 %), occurring after respective medians (IQR) of 3 (1–11), 21 (10–26), and 36 (8–63) days post-ECMO onset. Intracranial bleeding was independently associated with renal failure at intensive care unit admission and rapid PaCO2 decrease at ECMO initiation, but not with age, comorbidities, or hemostasis disorders. Seven (70 %) patients with intracranial bleeding and one (33 %) with ischemic stroke died versus 40 % of patients without neurological event. A systematic review found comparable intracranial bleeding rates (5 %).ConclusionsNeurological events occurred frequently in patients on VV-ECMO. Intracranial bleeding, the most frequent, occurred early and was associated with higher mortality. Because it was independently associated with rapid hypercapnia decrease, the latter should be avoided at ECMO onset, but its exact role remains to be determined. These findings may have major implications for the care of patients requiring VV-ECMO.

[1]  A. Rabinstein,et al.  Neurologic Complications of Extracorporeal Membrane Oxygenation , 2015, Journal of clinical neurology.

[2]  Extracorporeal Membrane Oxygenation for 2009 Influenza A ( H 1 N 1 ) Acute Respiratory Distress Syndrome , 2009 .

[3]  Alain Combes,et al.  Mechanical ventilation during extracorporeal membrane oxygenation , 2014, Critical Care.

[4]  M. Haller,et al.  Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment , 1999, Intensive Care Medicine.

[5]  W. Long,et al.  Pandemic flu and the sudden demand for ECMO resources: A mature trauma program can provide surge capacity in acute critical care crises , 2013, The journal of trauma and acute care surgery.

[6]  E. Farthmann,et al.  Extracorporeal membrane oxygenation: a ten-year experience. , 2000, American journal of surgery.

[7]  Michael Bailey,et al.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. , 2009, JAMA.

[8]  B. Griffith,et al.  Long-Term Venovenous Extracorporeal Membrane Oxygenation Support for Acute Respiratory Distress Syndrome. , 2015, The Annals of thoracic surgery.

[9]  R. Crone,et al.  Extracorporeal Membrane Oxygenation , 1992, Anesthesia and analgesia.

[10]  H. Kirkegaard,et al.  Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure , 2013, Acta anaesthesiologica Scandinavica.

[11]  P. Leprince,et al.  Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review , 2013, Critical Care.

[12]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[13]  M. Antonelli,et al.  The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks , 2011, Intensive Care Medicine.

[14]  Lingzhong Meng,et al.  Regulation of Cerebral Autoregulation by Carbon Dioxide , 2015, Anesthesiology.

[15]  J. Parisi,et al.  Neurological injury in adults treated with extracorporeal membrane oxygenation. , 2011, Archives of neurology.

[16]  K. Palmér,et al.  High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation , 2000, Intensive Care Medicine.

[17]  T. Dorman,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2011 .

[18]  W. Copen,et al.  Outcome in Patients with H1N1 Influenza and Cerebrovascular Injury Treated with Extracorporeal Membrane Oxygenation , 2011, Neurocritical care.

[19]  R. Bartlett,et al.  Extracorporeal life support for 100 adult patients with severe respiratory failure. , 1997, Annals of surgery.

[20]  C. Schlensak,et al.  Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS) , 2011, Intensive Care Medicine.

[21]  R. Bartlett,et al.  Extracorporeal Life Support: Experience with 2,000 Patients , 2015, ASAIO journal.

[22]  Arthur S Slutsky,et al.  Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. , 2014, American journal of respiratory and critical care medicine.

[23]  L. Le Guennec,et al.  Diffuse cerebral microbleeds after extracorporeal membrane oxygenation support. , 2015, American journal of respiratory and critical care medicine.

[24]  Diana Elbourne,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.

[25]  Sylvie Chevret,et al.  Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. , 2013, American journal of respiratory and critical care medicine.

[26]  L. Papazian,et al.  Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center , 2013, Intensive Care Medicine.

[27]  G. Ng,et al.  Three-year experience of using venovenous extracorporeal membrane oxygenation for patients with severe respiratory failure. , 2014, Hong Kong medical journal = Xianggang yi xue za zhi.

[28]  Susanna Price,et al.  Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). , 2011, JAMA.

[29]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[30]  P. Kranke,et al.  Effects of venovenous extracorporeal membrane oxygenation on cerebral oxygenation in hypercapnic ARDS , 2014, Perfusion.

[31]  N. Lassen,et al.  Physiology of cerebral blood flow. , 1976, British journal of anaesthesia.

[32]  N. Smedira,et al.  Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. , 1999, European Journal of Cardio-Thoracic Surgery.

[33]  Robert H. Bartlett,et al.  Extracorporeal Life Support for Severe Acute Respiratory Distress Syndrome in Adults , 2004, Annals of surgery.

[34]  Robert H. Bartlett,et al.  Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database , 2009, Intensive Care Medicine.

[35]  P. Leprince,et al.  Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults , 2013, Intensive Care Medicine.

[36]  Fabrice Carrat,et al.  Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. , 2012, Chest.

[37]  N. Roewer,et al.  Cerebral Tissue Oxygenation During the Initiation of Venovenous ECMO , 2014, ASAIO journal.